A novel Chimeric Antigen Receptor (CAR) - strategy to target EGFRVIII-mutated glioblastoma cells via macrophages.
Saved in:
| Title: | A novel Chimeric Antigen Receptor (CAR) - strategy to target EGFRVIII-mutated glioblastoma cells via macrophages. |
|---|---|
| Authors: | Vera K; INSERM UMR-S-1310, Paris Saclay University, Villejuif, 94800, France., Esken G; INSERM UMR-S-1310, Paris Saclay University, Villejuif, 94800, France., Hwang JW; INSERM UMR-S-1310, Paris Saclay University, Villejuif, 94800, France.; Faculty of Medicine Paris Saclay, Paris Saclay University, Le Kremlin Bicêtre, 94270, France., Elbaz C; INSERM UMR-S-1310, Paris Saclay University, Villejuif, 94800, France.; CITHERA, Centre for IPSC Therapies, INSERM UMS-45, Genopole Campus, Evry, 91100, France., Chaker D; INSERM UMR-S-1310, Paris Saclay University, Villejuif, 94800, France.; CITHERA, Centre for IPSC Therapies, INSERM UMS-45, Genopole Campus, Evry, 91100, France., Oudrhiri N; INSERM UMR-S-1310, Paris Saclay University, Villejuif, 94800, France.; APHP Paris Saclay, Department of Hematology, Hospital Bicêtre and Paul Brousse, Villejuif, 94800, France.; CITHERA, Centre for IPSC Therapies, INSERM UMS-45, Genopole Campus, Evry, 91100, France., Desterke C; INSERM UMR-S-1310, Paris Saclay University, Villejuif, 94800, France.; Faculty of Medicine Paris Saclay, Paris Saclay University, Le Kremlin Bicêtre, 94270, France., Griscelli F; INSERM UMR-S-1310, Paris Saclay University, Villejuif, 94800, France.; Department of Biology and Pathology, Gustave Roussy Cancer Center, Villejuif, 94000, France.; INGESTEM National iPSC Infrastructure, Villejuif, 94800, France.; CITHERA, Centre for IPSC Therapies, INSERM UMS-45, Genopole Campus, Evry, 91100, France., Bennaceur-Griscelli A; INSERM UMR-S-1310, Paris Saclay University, Villejuif, 94800, France.; Faculty of Medicine Paris Saclay, Paris Saclay University, Le Kremlin Bicêtre, 94270, France.; APHP Paris Saclay, Department of Hematology, Hospital Bicêtre and Paul Brousse, Villejuif, 94800, France.; INGESTEM National iPSC Infrastructure, Villejuif, 94800, France.; CITHERA, Centre for IPSC Therapies, INSERM UMS-45, Genopole Campus, Evry, 91100, France., Turhan AG; INSERM UMR-S-1310, Paris Saclay University, Villejuif, 94800, France. turviv33@gmail.com.; Faculty of Medicine Paris Saclay, Paris Saclay University, Le Kremlin Bicêtre, 94270, France. turviv33@gmail.com.; APHP Paris Saclay, Department of Hematology, Hospital Bicêtre and Paul Brousse, Villejuif, 94800, France. turviv33@gmail.com.; INGESTEM National iPSC Infrastructure, Villejuif, 94800, France. turviv33@gmail.com.; CITHERA, Centre for IPSC Therapies, INSERM UMS-45, Genopole Campus, Evry, 91100, France. turviv33@gmail.com. |
| Source: | BMC cancer [BMC Cancer] 2026 May 08; Vol. 26 (1). Date of Electronic Publication: 2026 May 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
